Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.6m
Position in Universe th / 6855

BRIEF-Juniper Pharmaceuticals reports Q1 loss per share $0.13

Thu 4th May, 2017 12:45pm
May 4 (Reuters) - Juniper Pharmaceuticals Inc  JNP.O :  
    * Juniper pharmaceuticals reports first quarter 2017 
financial and operating results 
    * Q1 loss per share $0.13 
    * Q1 revenue $11.2 million 
    * Frank Condella will not seek re-election to co's board of 
directors 
    * Juniper Pharmaceuticals Inc - expect to be in a position 
to file up to three ind's with U.S. Food and drug administration 
in first half of 2018 
    * Q1 earnings per share view $-0.09, revenue view $11.3 
million -- Thomson Reuters I/B/E/S 
 
Source text for Eikon:  ID:nPn2h2DMFa  
Further company coverage:  JNP.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.